IONIS PHARMACEUTICALS INC
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
As of February 13, 2025, the following are the primary facilities in which we operate:
| Property Description | Location | Square Footage | Owned or Leased | Initial Lease Term End Date | Lease Extension Options |
|---|---|---|---|---|---|
| Laboratory and office space facility | Carlsbad, CA | 176,300 | Leased | 2037 | Two, five-year options to extend |
| Office and meeting space facility | Carlsbad, CA | 74,000 | Leased | 2037 | Two, five-year options to extend |
| Manufacturing facility | Carlsbad, CA | 26,800 | Owned | ||
| Manufacturing support facility | Carlsbad, CA | 25,800 | Leased | 2026 | One, five-year option to extend |
| Office space facility | Boston, MA | 14,300 | Leased | 2029 | One, five-year option to extend |
| Office space facility | Carlsbad, CA | 5,800 | Leased | 2027 | None |
| Warehouse facility | Carlsbad, CA | 4,200 | Leased | 2028 | None |
| Office space facility | Dublin, Ireland | 3,900 | Leased | 2025 | None |
We believe that our current and future facilities will be adequate for the foreseeable future. Refer to Part IV, Section 15, Note 7, Long-Term Obligations and Commitments, in the Notes to the Consolidated Financial Statements for details on real estate transactions.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.